Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
CN Stock MarketDetailed Quotes
Zhejiang Orient Gene Biotech (688298)
- 24.90
- -0.33-1.31%
Market Closed Jan 16 15:00 CST
5.02BMarket Cap-10.47P/E (TTM)
25.43High24.70Low2.24MlotVolume25.35Open25.23Prev Close55.92MTurnover1.11%Turnover RatioLossP/E (Static)201.60MShares36.0052wk High0.79P/B5.02BFloat Cap21.1452wk Low30.28Limit Up201.60MShs Float239.67Historical High20.18Limit Down2.89%Range %21.14Historical Low--Dividend TTM24.92Avg Price1.15MlotAsk--Div Yield TTM1Lot Size967.44KlotBid
Zhejiang Orient Gene Biotech (688298) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 2.16%671.81M | -3.62%403.08M | 4.94%191.95M | 0.95%827.92M | 0.83%657.61M | -16.61%418.24M | -51.36%182.92M | -90.65%820.16M | -91.70%652.17M | -92.95%501.54M |
| Operating revenue | 2.16%671.81M | -3.62%403.08M | 4.94%191.95M | 0.95%827.92M | 0.83%657.61M | -16.61%418.24M | -51.36%182.92M | -90.65%820.16M | -91.70%652.17M | -92.95%501.54M |
| Total operating cost | -11.53%898.68M | -6.74%582.11M | 7.73%308.69M | 24.76%1.25B | 41.33%1.02B | 36.41%624.19M | -32.46%286.55M | -80.22%1B | -82.14%718.72M | -87.39%457.57M |
| Operating cost | -8.71%392.09M | -6.63%251.45M | 12.68%139.43M | 20.91%565.13M | 4.75%429.48M | -16.80%269.3M | -51.08%123.75M | -89.17%467.4M | -88.26%409.99M | -89.31%323.66M |
| Operating tax surcharges | 106.25%10.57M | 142.93%7.5M | 148.62%2.92M | 0.93%15.21M | -9.18%5.13M | -13.10%3.09M | -59.81%1.17M | -83.17%15.07M | -92.40%5.64M | -92.55%3.55M |
| Operating expense | 15.75%133.86M | 22.26%88.64M | 27.10%44.14M | 16.46%188.89M | -1.22%115.65M | -4.94%72.5M | -13.63%34.73M | -66.57%162.19M | -75.34%117.08M | -82.48%76.26M |
| Administration expense | -10.05%271.24M | -11.61%180.87M | -0.15%89.89M | 9.60%408.12M | 20.62%301.54M | 29.73%204.64M | 16.59%90.02M | 37.56%372.36M | 27.29%249.99M | 21.22%157.74M |
| Financial expense | -58.18%-72.64M | 16.21%-60.03M | 24.72%-26.42M | 21.14%-217.34M | 81.79%-45.92M | 68.49%-71.64M | -3,645.95%-35.09M | 54.32%-275.58M | 59.00%-252.11M | 36.69%-227.39M |
| -Interest expense (Financial expense) | -47.73%7.49M | -46.91%5.45M | 9.13%3.82M | 6.23%19.25M | 22.22%14.33M | 69.45%10.26M | 22.55%3.5M | 160.09%18.12M | 59.11%11.73M | 222.28%6.05M |
| -Interest Income (Financial expense) | 15.72%-70.57M | 33.70%-47.5M | 61.07%-16.76M | 7.06%-193M | 47.10%-83.74M | 29.15%-71.65M | -0.77%-43.05M | -77.73%-207.67M | -90.15%-158.3M | -152.46%-101.12M |
| Research and development | -22.07%163.55M | -22.30%113.68M | -18.40%58.73M | 11.36%290.49M | 11.56%209.88M | 18.23%146.3M | 38.65%71.96M | -49.01%260.86M | -52.99%188.14M | -64.40%123.74M |
| Credit Impairment Loss | -1,594.57%-6.27M | 119.83%1.29M | 22.85%-3.62M | -5.80%-29.13M | -1.44%419.63K | -2,780.04%-6.48M | -317.99%-4.69M | -573.14%-27.53M | -98.72%425.77K | 94.60%-224.96K |
| Asset Impairment Loss | 1.01%-16.47M | -54.29%-13.92M | -37.64%-4.47M | 25.71%-175.7M | -3.54%-16.64M | 0.40%-9.02M | -108.64%-3.25M | 80.45%-236.51M | 90.91%-16.07M | 95.11%-9.06M |
| Other net revenue | ||||||||||
| Fair value change income | -67.10%4.99M | -67.71%4.99M | -105.53%-1.56M | 218.52%10.65M | 1,730.91%15.16M | 1,763.22%15.46M | 3,127.97%28.15M | -641.47%-8.99M | -5,822.38%-929.53K | -5,822.38%-929.53K |
| Invest income | -92.20%5.52M | -91.80%3.48M | -83.90%2.46M | -29.13%29.78M | 132.89%70.76M | 98.60%42.5M | 43.84%15.28M | 597.51%42.01M | 455.66%30.38M | 310.41%21.4M |
| -Including: Investment income associates | 13.12%-2.08M | 17.38%-1.27M | 82.42%-151.37K | -101.49%-3.02M | -82.09%-2.39M | -235.75%-1.54M | -357.76%-861.11K | -178.28%-1.5M | ---1.31M | ---459.23K |
| Asset deal income | 85.65%1.68M | 3,258.07%1.74M | -326.15%-14.38K | 651.87%987.65K | 655.10%904.17K | -158.53%-55.15K | -95.53%6.36K | -2,150.74%-178.97K | -215.87%-162.88K | 24,739.67%94.23K |
| Other revenue | -35.73%3.21M | -33.60%2.5M | -32.44%459.87K | -75.70%7.17M | -40.98%5M | -31.23%3.76M | 53.58%680.7K | 20.13%29.5M | -35.15%8.47M | -44.73%5.47M |
| Operating profit | 17.11%-234.22M | -11.99%-178.95M | -83.07%-123.49M | -50.80%-578.83M | -535.82%-282.55M | -363.10%-159.78M | -4,565.92%-67.45M | -115.18%-383.83M | -101.20%-44.44M | -98.16%60.73M |
| Add:Non operating Income | -95.65%299.8K | -92.37%279.79K | 97.72%32.04K | 111.18%8.89M | 61.70%6.89M | -12.92%3.67M | -97.56%16.2K | 1,219.25%4.21M | 1,342.05%4.26M | 2,073.16%4.21M |
| Less:Non operating expense | -60.24%806.31K | -516.91%-5.56M | -82.28%120.29K | -37.52%15.37M | -66.54%2.03M | -76.72%1.33M | -98.16%678.7K | -57.42%24.6M | -85.66%6.06M | -76.18%5.73M |
| Total profit | 15.47%-234.72M | -9.95%-173.11M | -81.41%-123.57M | -44.80%-585.31M | -500.53%-277.69M | -365.89%-157.45M | -80.90%-68.12M | -116.36%-404.23M | -101.27%-46.24M | -98.19%59.22M |
| Less:Income tax cost | -2.58%-3.55M | -63.38%950.03K | -252.58%-2.8M | -217.42%-16.49M | -116.45%-3.46M | -87.80%2.59M | -79.01%1.84M | -96.24%14.04M | -96.29%21.03M | -95.69%21.27M |
| Net profit | 15.70%-231.17M | -8.76%-174.06M | -72.64%-120.77M | -35.99%-568.82M | -307.67%-274.23M | -521.76%-160.04M | -50.72%-69.96M | -119.94%-418.27M | -102.18%-67.27M | -98.63%37.95M |
| Net profit from continuing operation | 15.70%-231.17M | -8.76%-174.06M | -72.64%-120.77M | -35.99%-568.82M | -307.67%-274.23M | -521.76%-160.04M | -50.72%-69.96M | -119.94%-418.27M | -102.18%-67.27M | -98.63%37.95M |
| Less:Minority Profit | -53.60%-18.54M | -29.94%-10.96M | -104.38%-5.32M | -92.41%-39.8M | -335.88%-12.07M | -368.79%-8.44M | -166.42%-2.6M | -169.61%-20.69M | -85.31%5.12M | -90.99%3.14M |
| Net profit of parent company owners | 18.89%-212.63M | -7.58%-163.1M | -71.41%-115.45M | -33.06%-529.02M | -262.17%-262.16M | -535.56%-151.61M | -33.82%-67.35M | -119.23%-397.58M | -102.37%-72.38M | -98.73%34.81M |
| Earning per share | ||||||||||
| Basic earning per share | 16.67%-1.1 | -10.53%-0.84 | -72.73%-0.57 | -36.55%-2.69 | -266.67%-1.32 | -547.06%-0.76 | -10.00%-0.33 | -116.00%-1.97 | -101.98%-0.36 | -98.96%0.17 |
| Diluted earning per share | 16.67%-1.1 | -10.53%-0.84 | -72.73%-0.57 | -36.55%-2.69 | -266.67%-1.32 | -547.06%-0.76 | -10.00%-0.33 | -116.00%-1.97 | -101.98%-0.36 | -98.96%0.17 |
| Other composite income | -24.13%-21.79M | -949.65%-21.83M | 6.37%-7.82M | -11.19%12.53M | -170.56%-17.55M | -91.12%2.57M | 37.01%-8.35M | -65.58%14.11M | -64.03%24.88M | 9.20%28.92M |
| Other composite income of parent company owners | -24.13%-21.79M | -949.65%-21.83M | 6.37%-7.82M | -11.19%12.53M | -170.56%-17.55M | -91.12%2.57M | 37.01%-8.35M | -65.58%14.11M | -64.03%24.88M | 9.20%28.92M |
| Total composite income | 13.30%-252.96M | -24.39%-195.89M | -64.21%-128.59M | -37.64%-556.29M | -588.35%-291.78M | -335.51%-157.48M | -31.23%-78.31M | -118.90%-404.16M | -101.34%-42.39M | -97.61%66.87M |
| Total composite income of parent company owners | 16.19%-234.42M | -24.08%-184.92M | -62.83%-123.27M | -34.69%-516.49M | -488.79%-279.71M | -333.87%-149.04M | -19.05%-75.71M | -118.19%-383.48M | -101.52%-47.51M | -97.70%63.73M |
| Total composite income of minority owners | -53.60%-18.54M | -29.94%-10.96M | -104.38%-5.32M | -92.41%-39.8M | -335.88%-12.07M | -368.79%-8.44M | -166.42%-2.6M | -169.61%-20.69M | -85.31%5.12M | -90.99%3.14M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | -- | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"